Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis

Journal of Neuroimmunology

Volumn 91, Issue 1-2, 1998, Pages 147-155

  Nataf, Serge ^a   Davoust, Nathalie ^a   Barnum, Scott R ^a  

^a Division of Clinical Immunology and Rheumatology   (United States)

Author keywords

C5a receptor; Central nervous system; Complement; Experimental allergic encephalomyelitis; Multiple sclerosis

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT COMPONENT C5A;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; COMPLEMENT ACTIVATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; ANTIGENS, CD; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; KINETICS; MACROPHAGES; MICROGLIA; MONOCYTES; MULTIPLE SCLEROSIS; RATS; RATS, INBRED LEW; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RNA, MESSENGER; SPINAL CORD;

EID: 0032476636     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00169-6     Document Type: Article

References (41)

1. Akatsu H., Miwa T., Sakurada C., Fukuoka Y., Ember J.A., Yamamoto T., Hugli T.E., Okada H. cDNA cloning and characterization of rat C5a anaphylatoxin receptor. Microbiol. Immunol. 41:1997;575-580.
2. Armstrong R.C., Harvath L., Dubois-Dalcq M.E. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J. Neurosci. Res. 27:1990;400-407.
3. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
4. Barten D.M., Ruddle N.H. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J. Neuroimmunol. 51:1994;123-133.
5. Bauer J., Sminia T., Wouterlood F.G., Dijkstra C.D. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J. Neurosci. Res. 38:1994;365-375.
6. Chiang C.S., Powell H.C., Gold L.H., Samimi A., Campbell I.L. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J. Clin. Invest. 97:1996;1512-1524.
7. Ernst J.D., Hartiala K.T., Goldstein I.M., Sande A.M. Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect. Immun. 46:1984;81-86.
8. Faustmann P.M., Krause D., Dux R., Dermietzel R. Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes. Acta Neuropathol. 89:1995;239-247.
9. Fernandez H.N., Henson P.M., Otani A., Hugli T.E. Chemotactic response to human C3a and C5a anaphylatoxins: I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J. Immunol. 120:1978;109-115.
10. Feurer C., Prentice D.E., Cammisuli S. Chronic relapsing encephalomyelitis in the Lewis rat. J. Neuroimmunol. 10:1985;159-165.
11. Flaris N.A., Densmore T.L., Molleston M.C., Hickey W.F. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia. 7:1993;34-40.
12. Foreman K.E., Vaporciyan A.A., Bonish B.K., Jones M.L., Johnson K.J., Glovsky M.M., Eddy S.M., Ward P.A. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1994;1147-1155.
13. Gasque P., Chan P., Fontaine M., Ishenko A., Lamacz M., Götze O., Morgan B.P. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:1995;4882-4889.
14. Gasque P., Singhrao S.K., Neal J.W., Gotze O., Morgan B.P. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150:1997;31-41.
15. Gerard C., Gerard N.P. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:1994;775-808.
16. Glabinski A., Tani M., Aras S., Stoller M., Tuohy V., Ransohoff R.M. Regulation and function of central nervous system chemokines. Int. J. Dev. Neurosci. 13:1995;153-165.
17. Glabinski A.R., Tani M., Strieter R.M., Tuohy V.K., Ransohoff R.M. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:1997;617-630.
18. Hart M.N., Fabry Z. CNS antigen presentation. Trends Neurosci. 18:1995;475-481.
19. Kadurugamuwa J.L., Hengstler B., Bray M.A., Zak O. Inhibition of complement-factor-5a-induced inflammatory reactions by prostaglandin E2 in experimental meningitis. J. Infect. Dis. 160:1989;715-719.
20. Lacy M., Jones J., Whittemore S.R., Haviland D.L., Wetsel R.A., Barnum S.R. Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and fMLP by human astrocytes and microglia. J. Neuroimmunol. 61:1995;71-78.
21. Lassman, H., 1983. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Springer-Verlag, Berlin.
22. Linington C., Morgan B.P., Scolding N.J., Wilkins P., Piddlesden S., Compston D.A.S. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain. 112:1989;895-911.
23. Liu W.T., Vanguri P., Shin M.L. Studies on demyelination in vitro: the requirement of membrane attack components of the complement system. Ann. Neurol. 131:1983;778-782.
24. Matsumoto Y., Ohmori K., Fujiwara M. Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J. Neuroimmunol. 37:1992;23-33.
25. Müller-Ladner U., Jones J., Gay S., Wetsel R.A., Raine C., Barnum S.R. Enhanced expression of chemotactic receptors in multiple sclerosis lesions. J. Neurol. Sci. 144:1996;135-144.
26. Nataf S., Garcion E., Darcy F., Chabannes D., Muller J.Y., Brachet P. 1,25-dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J. Neuropathol. Exp. Neurol. 55:1996;904-914.
27. Paradisis, P.M., Campbell, I.L., Barnum, S.R., 1998. Elevated complement C5a receptor expression on glial cells and neurons induced by the central nervous system production of interleukin-3 in transgenic mice. Glia, in press.
28. Piddlesden S.J., Lassman H., Zimprich F., Morgan B.P., Linington C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143:1993;555-564.
29. Piddlesden S.J., Storch M.K., Hibbs M., Freeman A.M., Lassman H., Morgan B.P. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152:1994;5477-5484.
30. Sayah S., Patte C., Gasque P., Chan P., Ishenko A., Vaudry A., Fontaine M. Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes. Mol. Brain Res. 48:1997;215-222.
31. Schorey J.S., Carroll M.C., Brown E.J. A macrophage invasion mechanism of pathogenic mycobacteria. Nature. 277:1997;1091-1093.
32. Shin, M.L., Koski, C.L., 1992. The complement system in demyelination. In: Martenson, R.E. (Ed.), Myelin: Biology and Chemistry. Boca Raton, CRC Press, pp. 801-831.
33. Shin H.S., Snyderman R., Friedman E., Mellors A., Mayer M.M. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science. 162:1968;361-363.
34. Spiegel, K., Emmerling, M.R., Barnum, S.R., 1997. Acute phase proteins: Strategies for inhibition of complement activation in the treatment of neurodegenerative disorders. In: Totowa, W.P. (Ed.), Inflammatory Mechanisms and Management of Neurodegeneration. Humana Press, NJ, pp. 129-176.
35. Stahel P.F., Frei K., Eugster H.P., Fontana A., Hummel K.M., Wetsel R.A., Ames R., Barnum S.R. TNF-α-mediated expression of the receptor for anaphylatoxin C5a (C5aR) on neurons in experimental Listeria meningocephalitis. J. Immunol. 159:1997;861-869.
36. Stahel P.F., Kossmann T., Hans V., Morganti-Kossmann M.C., Barnum S.R. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor expression in rats. Mol. Brain Res. 50:1997;205-212.
37. Tuomanen E., Hengstler B., Zak O., Tomasz A. The role of complement in inflammation during experimental pneumococcal meningitis. Microb. Pathog. 1:1986;15-32.
38. Vanguri P., Koski C.L., Silverman B., Shin M.L. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. P.N.A.S. USA. 79:1982;3290-3294.
39. Villaroya H., Violleau K., Younes-Chenoufi A.B., Baumann N. Myelin-induced experimental allergic in Lewis rats: tumor necrosis factor a levels in serum and cerebrospinal fluid. Immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord. J. Neuroimmunol. 64:1996;105-118.
40. Wetsel R.A. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 1:1995;48-53.
41. Yao J., Harvath L., Gilbert D.L., Colton C.A. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27:1990;36-42.